Assorted News from the Last Week: AACR issued a Special Edition Advocacy Alert for National Cancer Survivor Month, with several pediatric-focused articles. Children’s brain tumors
Assorted News from the Last Week: The FDA has granted rare pediatric disease designation and orphan drug designation to FL118 for the treatment of patients
Assorted News from the Last Week: Black pediatric AML patients had more than twice the risk of acute kidney injury during treatment as their White
Assorted News from the Last Week: A large number of CAC2 members contributed to the recently published conclusions from the 2024 paediatric strategy forum for
Assorted News from the Last Week: The U.S. Food and Drug Administration (FDA) approved FoundationOne®CDx as a companion diagnostic for Supporting Organization Member Day One
Assorted News from the Last Week: Pope Francis tells pediatric cancer patients they are ‘witnesses of hope.’ Unraveling the relationship between stress exposure and childhood
Assorted News from the Last Week: GLO-BNHL opens first sites of a multi-country platform trial that will offer multiple new treatments and a better chance
Assorted News from the Last Week: Spending package extends medicare telehealth flexibilities for three months and Gabriella Miller Kids First 2.0 reauthorization passes in standalone
Assorted News from the Last Week: Special Advocacy Call to Action: CAC2 Supporting Organization LLS is spearheading an effort and inviting all in the community
Assorted News from the Last Week: The simple act of asking young patients about their symptoms regularly during cancer treatment can help them get more
